Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of ZNF217 polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Goat |
| Applications | ELISA,IHC-P |
More info about ZNF217 polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB7059 |
| Product name: | ZNF217 polyclonal antibody |
| Product description: | Goat polyclonal antibody raised against synthetic peptide of ZNF217. |
| Gene id: | 7764 |
| Gene name: | ZNF217 |
| Gene alias: | ZABC1 |
| Gene description: | zinc finger protein 217 |
| Immunogen: | A synthetic peptide corresponding to internal region of human ZNF217. |
| Immunogen sequence/protein sequence: | C-KNAADDSADKVNKN |
| Protein accession: | NP_006517.1 |
| Form: | Liquid |
| Concentration: | 0.5 mg/mL |
| Recommend dilutions: | ELISA (1:16000) Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (3-6 ug/mL) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In Tris saline, pH 7.3 (0.5% BSA, 0.02% sodium azide) |
| Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Goat |
| Antigen species / target species: | Human |
| Reactivity: | Human |
| Application image: |  |
| Application image note: | ZNF217 polyclonal antibody (Cat # PAB7059) (3.8 ug/mL) staining of paraffin embedded human prostate. Steamed antigen retrieval with citrate buffer pH 6, AP-staining. |
| Applications: | ELISA,IHC-P |
| Shipping condition: | Dry Ice |
| Publications: | ZNF217 suppresses cell death associated with chemotherapy and telomere dysfunction.Huang G, Krig S, Kowbel D, Xu H, Hyun B, Volik S, Feuerstein B, Mills GB, Stokoe D, Yaswen P, Collins C. Hum Mol Genet. 2005 Nov 1;14(21):3219-25. Epub 2005 Oct 3. |